| Name | Title | Contact Details |
|---|---|---|
Karen Dvorak |
Chief Marketing Officer | Profile |
Kenny Landherr |
Chief Financial Officer | Profile |
Denise Steinbring |
Chief Marketing Officer | Profile |
Jessica Parks |
Executive Assistant & Chief Financial Officer | Profile |
JeanAnn Trombley |
Chief Human Resources Officer | Profile |
Newhouse Specialty Co Inc is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dds Lab,Inc is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Med Assure is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Halyard Health is a medical technology company focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. We deliver clinically-superior products and solutions in infection prevention, surgical solutions, respiratory health, digestive health, pain management and IV therapy. Halyard Health became an independent company headquartered in Alpharetta, Georgia on November 1, 2014. Halyard operates 12 global manufacturing facilities with 16,500 employees worldwide – generating approximately $1.7 billion in net revenues. Halyard Health is traded on the New York Stock Exchange under the ticker symbol “HYH”.
LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest laser footprint and thoughtful ergonomic design that accommodates most operating rooms. The LENSAR Laser System has been cleared by FDA for anterior capsulotomy, lens fragmentation, and corneal and arcuate incisions. For other indications it is an investigational device limited by U.S. law to investigational use only